Definitive Healthcare Corp (DH)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $140.38M
Last updated: Nov 17, 2026 at 4:26 PM ET
Definitive Healthcare Corp (DH) Statistics
Definitive Healthcare (DH) has a market cap of $140.38M and an enterprise value of $121.78M. It kept -97.82% of revenue as net income over the last 12 months. Its trailing P/E of 9.4x is below its 5-year median of 16.6x.
Total Valuation
Enterprise value is 13.25% below the market cap, as cash exceeds debt.
| Market Cap | $140.38M |
|---|---|
| Enterprise Value | $121.78M |
| Latest price (Nov 17, 2026) | $1.31 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.6x and 1.0x. Its year-end P/E ranged from 11.7x to 45.8x from 2022 to 2025.
| P/E Ratio | 9.4x |
|---|---|
| Forward P/E | 6.5x |
| P/S Ratio | 0.6x |
| Forward P/S | 0.6x |
| P/B Ratio | 1.0x |
| P/FCF Ratio | 5.8x |
| P/OCF Ratio | 3.8x |
Enterprise Valuation
Counting debt and cash, the company is valued at 5.0x free cash flow.
| EV / Sales | 0.5x |
|---|---|
| EV / FCF | 5.0x |
Price Statistics
The stock is down 52.19% over 52 weeks and trades 23.58% above its 50-day average.
| Beta (1Y) | 1.25 |
|---|---|
| 52-Week Change | -52.19% |
| 1-Month Change | +19.09% |
| 3-Month Change | +82.45% |
| 6-Month Change | +50.38% |
| 5-Year Change | -97.21% |
| Total Return (1Y) | -52.19% |
| Total Return (3Y CAGR) | -45.60% |
| Total Return (5Y CAGR) | -47.55% |
| Return vs SPY (1Y) | -61.17% |
| Max Drawdown (1Y) | -78.12% |
| Max Drawdown (3Y) | -93.88% |
| Sharpe Ratio (1Y) | -0.89 |
| Correlation with SPY (1Y) | 0.22 |
| 50-Day Average | $1.06 |
| 200-Day Average | $1.01 |
| 52-Week Range | $0.61 to $3.00 |
| RSI (14 Days) | 65.6 |
| Average Volume (20 Days) | 419.58K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.96x current liabilities, and total debt is 1.09x shareholder equity.
| Current Ratio | 1.96x |
|---|---|
| Quick Ratio | 1.96x |
| Debt / Equity | 1.09x |
| Debt / FCF | 6.55x |
| Interest Coverage | -20.52x |
Returns and Efficiency
Return on invested capital is -71.42% over the last 12 months, against a 5-year average of -31.92%.
| Return on Equity (ROE) | -153.00% |
|---|---|
| Return on Assets (ROA) | -45.50% |
| Return on Invested Capital (ROIC) | -71.42% |
| Return on Capital Employed (ROCE) | -60.70% |
| ROE (5Y Average) | -49.46% |
| ROA (5Y Average) | -20.27% |
| ROIC (5Y Average) | -31.92% |
| Asset Turnover | 0.37x |
| Receivables Turnover | 7.52x |
Scores
DH has an Altman Z-Score of -3.11, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -3.11 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $227.31M over the last 12 months is down 6.18% from the 12 months before.
| Revenue | $227.31M |
|---|---|
| Revenue Growth (YoY) | -6.18% |
| Gross Profit | $171.33M |
| Operating Income | -$239.63M |
| Pretax Income | -$226.69M |
| Net Income | -$222.36M |
| EBITDA | -$151.96M |
| EBIT | -$221.25M |
| Reported EPS (TTM) | $0.14 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 29.74% of the $488.65M in total assets.
| Cash and Equivalents | $177.14M |
|---|---|
| Total Debt | $158.53M |
| Net Cash | $18.60M |
| Net Cash Per Share | $0.17 |
| Working Capital | $119.57M |
| Shareholder Equity | $145.33M |
| Book Value Per Share | $1.36 |
| Tangible Book Value | -$66.01M |
| Total Assets | $488.65M |
| Total Liabilities | $300.19M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $12.97M of capital spending, operating cash flow left $24.19M of free cash flow.
| Operating Cash Flow | $37.16M |
|---|---|
| Capital Expenditures | $12.97M |
| Free Cash Flow | $24.19M |
| FCF Per Share | $0.23 |
| Depreciation and Amortization | $69.29M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -105.42%.
| Gross Margin | 75.37% |
|---|---|
| Operating Margin | -105.42% |
| Pretax Margin | -99.73% |
| Net Margin | -97.82% |
| EBITDA Margin | -66.85% |
| EBIT Margin | -97.34% |
| FCF Margin | 10.64% |
| Gross Margin (5Y Average) | 78.33% |
| Net Margin (5Y Average) | -96.12% |
Growth
Revenue grew 2.75% a year over 3 years, and EPS fell 5.90% a year.
| Revenue Growth (3Y CAGR) | +2.75% |
|---|---|
| Revenue Growth (5Y CAGR) | +15.34% |
| EPS Growth (3Y CAGR) | -5.90% |
| FCF Growth (3Y CAGR) | +10.79% |
| FCF Growth (5Y CAGR) | +11.17% |
| Book Value Per Share Growth (2Y CAGR) | -39.37% |
Dividends and Yields
DH does not pay a dividend. Its free cash flow yield is 17.30%.
| Earnings Yield | 10.64% |
|---|---|
| FCF Yield | 17.30% |
| Buyback Yield | 0.00% |
Peer Position
Against 5 similar companies, DH has the 4th highest P/E.
P/E RatioPeer median 13.0x
P/S RatioPeer median 1.8x
ROICPeer median -13.60%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +6.60%
| P/E Ratio | 9.4x vs 13.0x median |
|---|---|
| P/S Ratio | 0.6x vs 1.8x median |
| ROIC | -71.42% vs -13.60% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -6.18% vs +6.60% median |
Analyst Forecast
Consensus estimates put revenue growth at -4.45% and EPS growth at -3.56% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -4.45% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -3.56% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About DH
What is DH's market cap?
Definitive Healthcare has a market cap of $140.38M. Its enterprise value, which adds debt and subtracts cash, is $121.78M.
What is DH's P/E ratio?
Definitive Healthcare has a trailing P/E ratio of 9.4x and a forward P/E of 6.5x.
How many shares of DH are outstanding?
Definitive Healthcare has 106.77M shares outstanding. The count is up 2.88% from a year earlier.
Does DH pay a dividend?
No. Definitive Healthcare does not pay a dividend.
How much debt does DH have?
Definitive Healthcare has $158.53M of total debt and $177.14M of cash and equivalents, a net cash position of $18.60M.
DH pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts